Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MitoQ and Microvascular Function in Healthy Black and White Adults
NCT06424756Phase 2Recruiting
- Sponsor
- University of Georgia
- Start
- Jul 2024
- Primary completion
- Mar 2030
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hypertension (HTN) and cardiovascular disease (CVD), sponsored by University of Georgia. Primary endpoints: Cutaneous microvascular responses to local heating at 1 hour and Flow-mediated dilation responses at 1 hour. Started Jul 2024; status: recruiting.
02
Conditions
hypertension (HTN)cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT06424756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06424756.